|
1
|
Leal J, Luengo-Fernandez R, Sullivan R and
Witjes JA: Economic burden of bladder cancer across the European
union. Eur Urol. 69:438–447. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Berdik C: Unlocking bladder cancer.
Nature. 551:S34–S35. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sameni S and Hande MP: Plumbagin triggers
DNA damage response, telomere dysfunction and genome instability of
human breast cancer cells. Biomed Pharmacother. 82:256–268. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marzec P, Armenise C, Pérot G, Roumelioti
FM, Basyuk E, Gagos S, Chibon F and Déjardin J:
Nuclear-receptor-mediated telomere insertion leads to genome
instability in ALT cancers. Cell. 160:913–927. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fujii Y: Prediction models for progression
of non-muscle-invasive bladder cancer: A review. Int J Urol.
25:212–218. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Knowles MA and Hurst CD: Molecular biology
of bladder cancer: New insights into pathogenesis and clinical
diversity. Nat Rev Cancer. 15:25–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Morrison CD, Liu P, Woloszynska-Read A,
Zhang J, Luo W, Qin M, Bshara W, Conroy JM, Sabatini L, Vedell P,
et al: Whole-genome sequencing identifies genomic heterogeneity at
a nucleotide and chromosomal level in bladder cancer. Proc Natl
Acad Sci USA. 111:E672–E681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nagata M, Muto S and Horie S: Molecular
biomarkers in bladder cancer: Novel potential indicators of
prognosis and treatment outcomes. Dis Markers. 2016:82058362016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Newman JA and Gileadi O: RecQ helicases in
DNA repair and cancer targets. Essays Biochem. 64:819–830. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Larsen NB and Hickson ID: RecQ helicases:
Conserved guardians of genomic integrity. In: DNA Helicases and DNA
Motor Proteins. Advances in Experimental Medicine and Biology. Vol.
767. Spies M: Springer; New York, NY: pp. 161–184. 2013, View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Croteau DL, Popuri V, Opresko PL and Bohr
VA: Human RecQ helicases in DNA repair, recombination, and
replication. Annu Rev Biochem. 83:519–552. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Krogh BO and Symington LS: Recombination
proteins in yeast. Annu Rev Genet. 38:233–271. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Traverso G, Bettegowda C, Kraus J,
Speicher MR, Kinzler KW, Vogelstein B and Lengauer C:
Hyper-recombination and genetic instability in BLM-deficient
epithelial cells. Cancer Res. 63:8578–8581. 2003.PubMed/NCBI
|
|
15
|
Hickson ID: RecQ helicases: Caretakers of
the genome. Nat Rev Cancer. 3:169–178. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chandra S, Priyadarshini R, Madhavan V,
Tikoo S, Hussain M, Mudgal R, Modi P, Srivastava V and Sengupta S:
Enhancement of c-Myc degradation by BLM helicase leads to delayed
tumor initiation. J Cell Sci. 126:3782–3795. 2013.PubMed/NCBI
|
|
17
|
Turley H, Wu L, Canamero M, Gatter KC and
Hickson ID: The distribution and expression of the Bloom's syndrome
gene product in normal and neoplastic human cells. Br J Cancer.
85:261–265. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Anisimenko MS, Kozyakov AE, Paul GA and
Kovalenko SP: The frequency of the BLM p.Q548X (c.1642C>T)
mutation in breast cancer patients from Russia is no higher than in
the general population. Breast Cancer Res Treat. 148:689–690. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Prokofyeva D, Bogdanova N, Dubrowinskaja
N, Bermisheva M, Takhirova Z, Antonenkova N, Turmanov N, Datsyuk I,
Gantsev S, Christiansen H, et al: Nonsense mutation p.Q548X in BLM,
the gene mutated in Bloom's syndrome, is associated with breast
cancer in Slavic populations. Breast Cancer Res Treat. 137:533–539.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mao FJ, Sidorova JM, Lauper JM, Emond MJ
and Monnat RJ: The human WRN and BLM RecQ helicases differentially
regulate cell proliferation and survival after chemotherapeutic DNA
damage. Cancer Res. 70:6548–6555. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang X, Lu X, Zhou G, Lou H and Luo G:
RECQL5 is an important determinant for camptothecin tolerance in
human colorectal cancer cells. Biosci Rep. 31:363–369. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kumari A, Owen N, Juarez E and McCullough
AK: BLM protein mitigates formaldehyde-induced genomic instability.
DNA Repair (Amst). 28:73–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Arora A, Abdel-Fatah TM, Agarwal D,
Doherty R, Moseley PM, Aleskandarany MA, Green AR, Ball G,
Alshareeda AT, Rakha EA, et al: Transcriptomic and protein
expression analysis reveals clinicopathological significance of
bloom syndrome helicase (BLM) in breast cancer. Mol Cancer Ther.
14:1057–1065. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lao VV, Welcsh P, Luo Y, Carter KT,
Dzieciatkowski S, Dintzis S, Meza J, Sarvetnick NE, Monnat RJ Jr,
Loeb LA and Grady WM: Altered RECQ helicase expression in sporadic
primary colorectal cancers. Transl Oncol. 6:458–469. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Singh DK, Popuri V, Kulikowicz T, Shevelev
I, Ghosh AK, Ramamoorthy M, Rossi ML, Janscak P, Croteau DL and
Bohr VA: The human RecQ helicases BLM and RECQL4 cooperate to
preserve genome stability. Nucleic Acids Res. 40:6632–6648. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Saleh-Gohari N and Helleday T:
Conservative homologous recombination preferentially repairs DNA
double-strand breaks in the S phase of the cell cycle in human
cells. Nucleic Acids Res. 32:3683–3688. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen K, Xu H and Zhao J: Bloom syndrome
protein activates AKT and PRAS40 in prostate cancer cells. Oxid Med
Cell Longev. 2019.2019:3685817, 2019. View Article : Google Scholar
|
|
29
|
Roos WP and Kaina B: DNA damage-induced
cell death by apoptosis. Trends Mol Med. 12:440–450. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma J, Setton J, Lee NY, Riaz N and Powell
SN: The therapeutic significance of mutational signatures from DNA
repair deficiency in cancer. Nat Commun. 9:32922018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tikoo S and Sengupta S: Time to bloom.
Genome Integr. 4:142010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Böhm S and Bernstein KA: The role of
post-translational modifications in fine-tuning BLM helicase
function during DNA repair. DNA Repair (Amst). 22:123–132. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang W, Yang S and Liu J, Bao L, Lu H, Li
H, Pan W, Jiao Y, He Z and Liu J: Screening antiproliferative drug
for breast cancer from bisbenzylisoquinoline alkaloid tetrandrine
and fangchinoline derivatives by targeting BLM helicase. BMC
Cancer. 19:10092019. View Article : Google Scholar : PubMed/NCBI
|
